Literature DB >> 14674717

APRT from erythrocytes of HGPRT deficient patients: kinetic, regulatory and thermostability properties.

Javier Crespillo1, Pilar Llorente, Luisa Argomániz, Celia Montero.   

Abstract

Adenine phosphoribosyltransferase (APRT) has been 1200-fold purified from erythrocytes of a patient with partial hipoxanthine-guanine phosphoribosyltransferase (HGPRT) deficiency, Propositus, and in those of a controlHPRT+, with 20% efficiency in both proteins and specific activity of 550 and 243 nmol/h/mgprotein. The specific activity determined in the Propositus enzyme was, in all purification steps, higher than that of the controlHPRT+. Significant changes were found in their thermal stabilities. Half inactivation times at each temperature studied are greater for the Propositus enzyme in the temperature interval 60-80 degrees C. No significant difference has been observed in the affinity constants for adenine and PRPP substrates. Studies on inhibition by the reaction product suggest that AMP is a competitive inhibitor with respect to PRPP in both enzymes, with Ki values of 150 microM in Propositus and 220 microM in controlHPRT+.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14674717     DOI: 10.1023/a:1027323521969

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

1.  Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase.

Authors:  F M Rosenbloom; J F Henderson; I C Caldwell; W N Kelley; J E Seegmiller
Journal:  J Biol Chem       Date:  1968-03-25       Impact factor: 5.157

2.  Human adenine phosphoribosyltransferase. Affinity purification, subunit structure, amino acid composition, and peptide mapping.

Authors:  J A Holden; G S Meredith; W N Kelley
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

3.  Human adenine phosphoribosyltransferase. Complete amino acid sequence of the erythrocyte enzyme.

Authors:  J M Wilson; T E O'Toole; P Argos; D S Shewach; P E Daddona; W N Kelley
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

4.  Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase.

Authors:  A Cohen; D Doyle; D W Martin; A J Ammann
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

5.  Adenine phosphoribosyltransferase in patients with disorders of purine and pyrimidine metabolism.

Authors:  J M Wilson; P E Daddona; T Otoadese; W N Kelley
Journal:  J Lab Clin Med       Date:  1982-02

6.  Complete deficiency of adenine phosphoribosyl transferase: report of a new family.

Authors:  T Nakamoto; H Nakatsu; T Kishi; N Sakura; T Usui; H Nihira
Journal:  J Urol       Date:  1983-09       Impact factor: 7.450

7.  Assignment of the gene for adenine phosphoribosyltransferase to human chromosome 16 by mouse-human somatic cell hybridization.

Authors:  J A Tischfield; F H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

8.  Artemia purine phosphoribosyltransferases. Purification and characterization.

Authors:  C Montero; P Llorente
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

9.  Further studies on the purine phosphoribosyltransferase 'burst' velocity reaction.

Authors:  C Montero; P Llorente
Journal:  Biochim Biophys Acta       Date:  1991-07-09

10.  Adenine phosphoribosyltransferase deficiency with renal deposition of 2,8-dihydroxyadenine leading to nephrolithiasis and chronic renal failure.

Authors:  K H Fye; A Sahota; D C Hancock; A B Gelb; J Chen; J W Sparks; R K Sibley; J A Tischfield
Journal:  Arch Intern Med       Date:  1993-03-22
View more
  1 in total

1.  Extreme pathway analysis reveals the organizing rules of metabolic regulation.

Authors:  Yanping Xi; Fei Wang
Journal:  PLoS One       Date:  2019-02-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.